Here are five things to know:
1. The new investors for the most recent financing round include MVM Life Science Partners, which led the round.
2. Existing investors that participated in the most recent round of investments include Leerink Revelation Partners, Pitango Venture Capital, ONSET Ventures and Aweida Venture Partners.
3. Vertos plans to use proceeds from the financing round to expand commercialization of mild, the company’s procedure designed to remove the cause of spinal stenosis through a minimally invasive incision.
4. CMS granted broad coverage for mild in December 2016 and the company will also use the latest round of funding to meet demand for the procedure.
5. MVM Partner Hugo Harrod joined Vertos Medical’s board of directors with the last round of financing.
More articles on orthopedic devices:
Hiring patterns post device tad suspension for 4 large orthopedic, spine companies
Stryker partners with GE on additive manufacturing
6 trends in the personalized orthopedic market
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.